Core Insights - Berkshire Hathaway has announced a definitive agreement to acquire Occidental Petroleum's chemical division, OxyChem, for $9.7 billion in cash, marking its largest transaction in three years [1][3] - This acquisition reflects Berkshire's strategy of investing in profitable, real-world industrial assets rather than chasing high-growth momentum [2][5] - The deal is expected to close in the fourth quarter of 2025, pending regulatory approvals, and will be funded from Berkshire's cash reserves, which were nearly $340 billion at the end of the last quarter [9] Strategic Importance - The acquisition aligns with Berkshire's historical approach of purchasing robust businesses that are leaders in their fields, transforming low-yielding cash into a profitable asset [3][4] - This move demonstrates a disciplined financial approach, as management identified an external opportunity that is believed to create more long-term value than share repurchases [7][13] - The acquisition of OxyChem, a global producer of essential commodity chemicals, provides a stable demand base and consistent performance, with a reported pre-tax income of $213 million for the second quarter of 2025 [9] Leadership and Future Outlook - Vice Chairman Greg Abel, the designated successor to Warren Buffett, played a key role in this transaction, signaling continuity in leadership and capital allocation decisions [6] - The acquisition reinforces Berkshire's core philosophy and strategic focus, prioritizing stable earnings over speculative gains, solidifying its status as a cornerstone investment for long-term value [10][13] - Berkshire's stock has delivered a year-to-date gain of approximately 10%, reflecting a deliberate strategic choice to avoid high-valuation technology sectors [10][11]
How Berkshire's OxyChem Buy Cements Its Long-Term Strength